CommercialCoverageLow impact
Tonic Motor Activation (TOMAC) for Restless Legs Syndrome
Blue Cross & Blue Shield of Mississippi·Neurology, Sleep Medicine, Family Medicine +1 more·Medical Policy
Effective date
Dec 1, 2025
We identified it
Jun 20, 2026
Summary
Blue Cross Blue Shield has added a new policy classifying Tonic Motor Activation (TOMAC) devices for treating restless legs syndrome as investigational and not covered. The policy specifically affects billing codes A4544 and E0743 for external nerve stimulators used in RLS treatment.
Action Required
By December 1, 2025: Billing team must update system to flag HCPCS codes A4544 and E0743 as non-covered/investigational for BCBS plans. Notify providers that TOMAC devices for restless legs syndrome will not be reimbursed by BCBS. Update prior authorization systems to automatically deny these codes as investigational.